Valeant, Bill Ackman bid $45B for Botox-maker Allergan
Tuesday, April 22, 2014 - 11:00
in Mathematics & Economics
Montreal-based Valeant Pharmaceuticals and activist investor Bill Ackman have unveiled details of their offer to buy Botox maker Allergan, proposing a cash-and-stock deal that could be worth about $45 billion — if they overcome the California-based specialty drug company's reluctance.